U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07829081) titled 'Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors' on Sept. 14.
Brief Summary: This cohort study is divided into two parts:
Part A: Registry Cohort All patients with non-metastatic, MMRd/MSI-H colorectal cancers (and other gastrointestinal cancers for exploratory analysis) who have signed the general research consent will be included in a prospective registry. This includes patients who undergo primary surgical resection (+/- neoadjuvant/adjuvant therapy) or following immunotherapy, regardless of response.
Part A is a multicenter observational registry with both prospective a...